Status: Not yet recruiting
Brazilian Prospective Registry of the Inspiron EVO Drug-Eluting Stent in Complex Coronary Lesions
The objective is to evaluate the efficacy and safety of the Inspiron™ EVO drug-eluting stent in complex coronary lesions in a real-world population. Patients with symptomatic ischemic heart disease due to lesions in native coronary arteries and restenotic lesions will be treated with the Inspiron™ EVO drug-eluting stent.
Participants needed: 2,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Scitech Produtos Medicos SAUpdated: Mar 30, 2026Locations: 1Duration: 12 Months
Eligibility criteria
Individuals aged 18 years or older presenting with complex coronary lesions requ... [+6]
Lesions in saphenous vein grafts or internal mammary grafts. [+2]